目的 :了解充血性心衰 (CHF)中钙通道阻滞剂使用现状 ,提高用药水平。方法 :对一年来广东省人民医院心内科、心外科的 986例CHF病例作横断面调查 ,依据CHF治疗指南并结合最新循证医学的证据对用药情况作客观评估。结果 :2 6 .0 %的患者使用过钙通道阻滞剂 ;地尔硫芯卓 、硝苯地平和氨氯地平使用率占前 3位 ,分别为 1 2 .5 % ,6 .1 %和 5 .1 %。结论 :与发达国家治疗指南有一定差距 ,主要体现为钙通道阻滞剂的过度使用 Objective: To understand the current status of calcium channel blockers in congestive heart failure (CHF) and improve the level of medication. Methods: A total of 986 cases of CHF in Department of Cardiology and Cardiology of Guangdong Provincial People’s Hospital in the past year were surveyed by cross-sectional investigation. Based on the CHF treatment guidelines and the evidence of the latest evidence-based medicine, objective evaluation of drug use was made. RESULTS: Twenty-six percent of patients had used calcium channel blockers; the top three were Diltiazem, nifedipine and amlodipine, which were respectively 12.5%, 6.1% and 5 .1%. Conclusion: There is a certain gap between the treatment guidelines in developed countries and the overuse of calcium channel blockers